Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) today announced the appointment of Kathy Rouan, PhD, to the Company’s board of directors, effective ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Management Changes Management Comments

Navidea Biopharmaceuticals Appoints Dr. Kathy Rouan to Board of DirectorsNovember 26, 2018 4:30 PM